Palantir is growing like a weed, but its valuations are getting overheated. UiPath faces tough near-term challenges, but its stock looks a lot cheaper. Both stocks are risky plays in this frothy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback